-
Two Alzheimer’s drugs offer hope to patients after decades of waiting
In clinical trials, the medications slowed the progress of the degenerative disease that affects 50mn worldwide
-
US regulators approve first drug to slow progression of Alzheimer’s
Move by Food and Drug Administration paves way for millions of Americans to access medicine
-
Eli Lilly drug shown to slow Alzheimer’s progression
Dementia experts hail ‘watershed moment’ after trial results for donanemab antibody treatment
-
Western capitals must keep lines open to Moscow
Ukraine fears being sold out but the US and its allies can use secret talks to convince Putin of their resolve
-
Microsoft to face EU competition probe over Teams and Office bundling
Investigation will centre on claims US tech giant is unfairly linking its videoconferencing app with popular software
-
Russia halts traffic over Crimea bridge after reports of explosion
Two people die after partial collapse of bridge that connects occupied peninsula to Russia
-
Russia pulls out of Black Sea grain deal
Moscow’s move puts at risk tens of millions of tonnes of food exports from Ukraine
-
European stocks follow Asia lower on weak Chinese economic data
Disappointing figures weigh on oil, pushing prices down 1%
0161 413 0666
